PillFentanyl Citrate
Fentanyl Citrate
2 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it2 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | unknown | 7 | SUPPLYING |
| Civica, Inc. | unknown | 2 | SUPPLYING |
| Phlow Corporation | unknown | 1 | EXITED 2028 |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Dec 20, 2023SHORTAGEDrug shortage: Fentanyl Citrate Injection (Hikma Pharmaceuticals USA, Inc.)
Fentanyl Citrate Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Analgesia/Addiction, Pediatric.
- May 13, 2015RECALLRecall (Class III): Fentanyl Citrate Inj., USP, CII, 250 mcg/5 mL (50 mcg/mL) (0.05 mg/mL), Rx Only, For IV or IM Use Preservative Free, 25…
Failed Impurities/Degradation Specifications; 12 month stability testing (Expansion of RES #70548). — Recalling firm: West-Ward Pharmaceutical Corp. — Nationwide
- Feb 16, 2015RECALLRecall (Class III): Fentanyl Citrate Inj., USP, CII, 250 mcg/5 mL (50 mcg/mL) (0.05 mg/mL) 25 x 5 mL Single Dose Vials, For Intravenous or …
Failed Impurities/Degradation Specifications; 12 month stability testing. — Recalling firm: West-Ward Pharmaceutical Corporation — Nationwide